BMRN Halts VOXZOGO Trials in Turner Syndrome, SHOX, ACAN Deficiencies After SCFE Events; Phase 2 CANOPY Continues; 10K Patient-Years Safety Data Shows No SCFE Cases
BioMarin Pharmaceuticals Inc · PHARMACEUTICAL PREPARATIONS · Now $57.29
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS